surgical infections rush Flashcards

1
Q

On the eighth day after an exploratory laparotomy and bowel
resection complicated by intraabdominal hypertension, a
65-year-old female who remains intubated in the intensive
care unit (ICU) develops a fever of 102°F. An infectious
workup reveals a new right lower lobe consolidation. When
initiating antibiotic therapy for presumed ventilator-associated pneumonia (VAP), which of the following does not treat
Pseudomonas aeruginosa?
A. Cefepime
B. Unasyn (ampicillin/sulbactam)
C. Ticarcillin
D. Aztreonam
E. Ciprofloxacin

A

ANSWER: B
COMMENTS: P. aeruginosa is a gram-negative bacillus commonly
implicated in VAP. Antipseudomonal antibiotics should be initiated
empirically in any patient with VAP prior to isolation of the organism
on culture due to the high mortality associated with pseudomonal
infection. Antipseudomonal penicillins include ticarcillin and piperacillin. Third- and fourth-generation cephalosporins, such as ceftazidime and cefepime, are effective against P. aeruginosa and have a
relatively narrow range of activity, making them preferred agents in
susceptible isolates. Monobactams (like aztreonam) and carbapenems (meropenem, imipenem) are effective, but have a very broad
spectrum of activity, and should be deescalated once susceptibilities
are available. Fluoroquinolones are also effective. The polymyxin
colistin is also effective, but has an extensive toxicity profile, and
should be used cautiously with multiresistant organisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A 67-year-old male remains in the hospital 1 week after
undergoing a pancreaticoduodenectomy. He has two intraabdominal closed-suction drains in place, as well as a left internal
jugular triple lumen catheter; his Foley catheter was removed on
the third postoperative day. On the seventh postoperative day, he
becomes febrile to 101.5°F, and a fever workup reveals a growth
of Enterococcus in two of two peripheral blood cultures. Which
of the following is true regarding the diagnosis of a central
line–associated bloodstream infection (CLABSI)?
A. It is preferential to begin empiric antimicrobial therapy
prior to obtaining cultures.
B. Catheter-site exudate, if present, should not be cultured
when there is concern for a line-related bloodstream
infection.
C. The subcutaneous portion of the central venous catheter
should be cultured, rather than the tip.
D. Paired blood samples (one from the catheter and one
from a peripheral vein, or alternatively from greater than
two lumens of the same central venous catheter) growing
the same organism at levels that meet catheter-related
bloodstream infection criteria are required to diagnose a
CLABSI.
E. Growth of greater than 10 colony-forming units (cfu) by
semiquantitative (roll-plate) culture confirms catheter
colonization.
ANSWER: D
COMMENTS: See Question 3.
Ref.: See Question 3
3. Which of the following is true regarding the treatment of
catheter-related bloodstream infections?
A. All catheters in cases of confirmed CLABSI should be
removed; it is never appropriate to attempt to salvage the
infected catheter.
B. Empiric coverage of Candida should be initiated in bone
marrow or solid organ transplant patients with presumed
CLABSI.
C. Empiric antibiotic therapy should include methicillinresistant Staphylococcus aureus (MRSA) coverage as
well as gram-negative rod (GNR) coverage, regardless of
the severity of illness.
D. Duration of antibiotic therapy in CLABSIs is timed from
the day when empiric antibiotics were initiated.
E. The location of a temporary central venous catheter
(subclavian versus internal jugular versus femoral) has no
influence on the empiric antibiotic agents that should be
used

A

ANSWER: B
COMMENTS: Central venous catheters are commonly used in
many settings in modern health care, but their use is associated with
the risk of bloodstream infections, known as CLABSIs. These
infections are known to increase morbidity, mortality, and health
care costs.
To diagnose a CLABSI, growth of greater than 15 cfu by
semiquantitative (roll-plate) culture from at least two samples is
required; these two samples may be obtained from the catheter and
a peripheral vein or, alternatively, from at least two lumens from
the same central venous catheter. The diagnosis of CLABSI is best
defined by a colony count threefold greater than that obtained from
a peripheral vein. Skin and catheter hubs should be prepared with
alcohol, tincture of iodine, or alcohol-based chlorhexidine (>0.5%)
with adequate drying time, prior to obtaining cultures; cultures
should be obtained by trained phlebotomists if possible.
Management of CLABSI varies based on the organism cultured and the severity of illness, but for all CLABSIs, the duration
of antimicrobial therapy is determined on the first day of obtaining
negative blood cultures. Preferably, adequate cultures are obtained
prior to the initiation of antibiotic therapy. Empiric therapy in
uncomplicated cases [i.e., cases without evidence of severe sepsis,
endocarditis or osteomyelitis (OM), or without evidence of infection of the catheter tunnel or adjacent abscess] should begin with
antibiotics that cover gram-positive cocci. Vancomycin or daptomycin for empiric therapy should be reserved for areas with a high
prevalence of MRSA. Empiric GNR coverage should be added in
cases of severe sepsis, neutropenia, in patients with known colonization with a GNR organism, or in patients with femoral catheters.
Empiric coverage for Candida, either with an echinocandin or a
fluconazole, should be initiated in patients with severe sepsis plus
prolonged broad-spectrum antibiotic use, total parenteral nutrition,
hematologic malignancy or receipt of solid organ or bone marrow
transplants, or known Candida colonization. In most circumstances,
the infected catheter should be removed; however, there are certain
instances in which salvage of the catheter may be attempted. Antibiotic locks (antibiotic solutions that are instilled into the catheter
itself) can be used in conjunction with systemic antimicrobial
therapy, particularly in patients in whom catheters are difficult to
remove or replace (i.e., tunneled hemodialysis catheters or ports for
parenteral nutrition in short gut syndrome). If patients have persistent positive blood cultures after salvage attempt, the catheter
should be removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

A 78-year-old man with a history of urinary retention and a
chronic indwelling urinary catheter is admitted to the hospital
from his nursing home with a new-onset altered mental status,
and a catheter-associated urinary tract infection (CAUTI) is
suspected. Which of the following is true regarding CAUTIs?
A. A 7-day antibiotic treatment is adequate for patients
whose symptoms respond promptly to treatment.
B. A CAUTI can be sufficiently diagnosed by the presence
of greater than 105 cfu/mL of at least one bacterial
species in a urine specimen.
C. Urine specimens being sent for culture can be obtained
from the catheter bag.
D. Pyuria is a specific indicator for urinary tract infections
(UTIs).
E. Proteus mirabilis is the most common organism cultured
in CAUTIs.

A

ANSWER: A
COMMENTS: CAUTIs are the most common health care–associated infection worldwide, and the most important factor leading to
nosocomial UTIs is urinary catheterization. The best prevention for
CAUTIs is avoiding catheterization. There are a limited number of
circumstances in which catheterization is appropriate, such as when
monitoring urine output in critically ill patients, in patients with
acute urinary retention or obstruction, in certain surgical procedures, or to facilitate healing of wounds or pressure ulcers in some
patients with urinary incontinence. A CAUTI is diagnosed by the
presence of greater than 103 cfu/mL of at least one bacterial species
in a catheter urine specimen or a midstream-voided urine specimen
in addition to clinical signs and symptoms suggestive of infection.
Signs and symptoms of a UTI include new-onset fever, rigors,
altered mental status, lethargy, malaise, flank pain, costovertebral
angle tenderness, hematuria, suprapubic or pelvic discomfort,
dysuria, urinary frequency, and urinary urgency. For these symptoms to be attributed to a catheter, the patient must have a current
indwelling urinary catheter or have had one within the 48 h preceding his or her symptoms. Without these symptoms, an infection
cannot be diagnosed. Catheter-associated asymptomatic bacteriuria
is more likely, and this is diagnosed by the presence of greater than
105 cfu/mL of at least one bacterial species in a urine specimen.
Catheters predispose to bacteriuria and UTIs in a variety of ways,
but formation of a biofilm along the catheter itself is the most
important predisposing factor. Pyuria is not specific for UTIs; it
can be seen in a variety of other renal pathologies and should not
be used as a diagnostic criterion for UTI. Urine culture specimens
are best collected by removing the catheter, if possible, to obtain a
voided midstream specimen, from the tubing or catheter itself in a
catheter that has been in place for less than 2 weeks, or by removing
any catheter that has been in place for greater than 2 weeks and
obtaining a specimen from the new catheter. The duration of antibiotic therapy should be 7 days for patients whose symptoms
respond promptly to antibiotics and 10 to 14 days for those whose
symptoms respond slowly. Escherichia coli is the most common
causative organism in CAUTIs, although Proteus is commonly
cultured in patients with chronic indwelling catheters.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A 57-year-old Asian American female presents to her
hepatologist’s office for monitoring of her known chronic
hepatitis B infection. Which of the following sets of test
results is consistent with chronic active hepatitis B infection?
A. Hepatitis B surface antigen (HBsAg)+ less than 6
months, hepatitis B surface antibody (HBsAb)−,
immunoglobulin M (IgM) anti-HBc+, elevated aspartate
transaminase (AST), and alanine transaminase (ALT)
B. HBsAg+ greater than 6 months, HBsAb−, HBcAb+,
hepatitis B virus (HBV) DNA > 20,000 IU/mL, mildly
elevated AST and ALT
C. HBsAg+ greater than 6 months, hepatitis B e antigen
(HBeAg)−, HBV DNA < 2000 IU/mL, normal AST and
ALT
D. HBsAg−, HBsAb+, HBcAb+, normal AST and ALT
E. HBsAg−, HBsAb+, HBcAb−, normal AST and ALT

A

ANSWER: B
COMMENTS: Answer A is acute hepatitis B infection; chronic
infection requires HBsAg positivity for at least 6 months. A patient 58 SECTION I / Surgical Fundamentals
with chronic active infection (answer B) exhibits normal to mildly
elevated liver enzymes and HBsAg positivity but negative HBsAb
since the infection has not been cleared; HBcAb will be positive
with chronic infection, and HBeAg may be positive as well if there
is a continued high level of viral replication; this is usually accompanied by a high level of HBV DNA. This is different from an
inactive carrier state (answer C); these patients have persistent
HBV infection of the liver without significant hepatic necrosis or
inflammation, so their liver enzymes are not significantly elevated;
there is a low level of viral replication, which correlates with negative HBeAg. Patients who have cleared HBV infection have evidence of HBsAb and HBcAb positivity (answer D). Answer E
reflects successful vaccination, with only HBsAb positivity on
serologic testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
Match the antibiotic and its classical toxicity profile.
A. Vancomycin a. Tendinopathy
B. Aminoglycosides b. Red man syndrome
C. Isoniazid (INH) c. Phototoxicity
D. Fluoroquinolones d. Hepatitis
E. Tetracycline e. Ototoxicity
A

ANSWER: A- b , B- e , C- d , D- a ,
E - c
COMMENTS: Vancomycin is known to cause red man syndrome,
a syndrome composed of flushing of the face, neck, and chest. It is
better described as a hypersensitivity reaction, rather than a true
allergy, because the effect is partly mediated by the speed with
which it is transfused. Aminoglycosides can cause ototoxicity
(cochlear and vestibular), which is dose dependent. The effects may
begin to be seen even after cessation of the drug; aminoglycoside
ototoxicity may be irreversible. INH can cause severe, sometimes
fulminant, hepatitis that is largely indistinguishable from acute viral
hepatitis. The mechanism of toxicity is not clear, but is thought to
be related to direct toxicity of the drug or its metabolites, and is
more likely to occur when other hepatitis risk factors are present,
such as concurrent alcohol consumption, use of other drugs that
utilize the cytochrome P450 system for metabolism, previous INH
intolerance, or prior or concurrent liver disease. Fluoroquinoloneinduced tendinopathy is rare, but it has been documented with
almost all drugs in this class. Tetracyclines cause cutaneous phototoxicity, so patients taking tetracyclines are cautioned to avoid sun
exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which of the following is not a Surgical Care Improvement
Project (SCIP) measure for infection prevention in surgical
patients?
A. The optimal timing for administration of prophylactic
antibiotics is within 1 h of surgical incision.
B. Prophylactic antibiotics should be discontinued within
24 h of the end of surgery; in cardiac surgery, this is
lengthened to 48 h.
C. Clippers are preferred to razors for preoperative hair
removal, if necessary.
D. Goal blood glucose in the first 48 h following surgery is
less than 160 mg/dL.
E. Patients should remain normothermic within the first hour
following surgery

A

ANSWER: D
COMMENTS: The SCIP summarizes specific tactics aimed at
prevention of surgical site infections (SSIs). Of the answer choices
listed above, only D is inaccurate; optimal blood glucose within the
first 48 h of surgery is less than 200 mg/dL. Hyperglycemia impairs
the host immune function and is known to increase the risk of
infection in both diabetic and nondiabetic patients. Moderate hyperglycemia (i.e., blood glucose > 200 mg/dL) in the first 24 h following surgery increases the risk of SSIs by a factor of four. Tight
blood glucose control has been a matter of debate in recent years,
with some arguing that very strict blood glucose control (i.e., less
than 110 mg/dL) results in significantly decreased rates of infection. However, postoperative hypoglycemia is associated with
increased mortality, so glycemic goals have been relaxed.
The remaining answer choices are correct. Prophylactic antibiotics should be given within 1 h of incision, though 2 h is appropriate
for fluoroquinolones and vancomycin, due to the prolonged infusion
times for these drugs. They should be discontinued within 24 h of
the end of surgery in all cases aside from the cardiac surgery, where
48 h of prophylactic antibiotic therapy is appropriate. Razors should
never be used to remove hair prior to procedures due to the increased
risk for small breaks in the skin, which might introduce infection;
clippers should be used preoperatively. Normothermia, defined as
any temperature between 96.8°F and 100.4°F, should be maintained
intraoperatively and for at least the first hour following surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Match the surgical procedure with the most appropriate
preoperative prophylactic antibiotic.
A. Elective laparoscopic cholecystectomy a. Ertapenem
B. Femoral to popliteal arterial bypass with graft b. Clindamycin
C. Cystoscopy with ureteral stent placement c. None
D. Right hemicolectomy d. Cefazolin
E. Parotidectomy e. Ciprofloxacin

A

ANSWER: A- c , B- d , C- e , D- a ,
E - b
COMMENTS: Prophylactic antibiotics administered preoperatively
should be targeted to the organisms most likely to be encountered in
the operative field. Broad-spectrum antibiotics do not have greater
efficacy at preventing SSIs than more narrow-spectrum, targeted
choices. The choice of prophylactic antibiotic therapy for intraabdominal surgeries varies widely depending on the exact location within the
gastrointestinal tract that is being manipulated. Low-risk biliary tract
procedures (e.g., elective laparoscopic cholecystectomy) do not require
surgical site infection prophylaxis; however, patients undergoing open
or complicated procedures involving the biliary tract should receive
antibiotics covering enteric GNRs, Enterococcus, and Clostridia.
Comparatively, colorectal surgery requires broad coverage of enteric
GNRs, anaerobes, and Enterococcus, which may be accomplished
with ertapenem, a carbapenem antibiotic. Cystoscopy with manipulation, such as the placement of ureteral stents, necessitates coverage of
enteric GNRs and Enterococcus; compared with colorectal surgery,
anaerobic coverage is not necessary. Vascular SSIs are most commonly
caused by skin flora, such as Staphylococcus and Streptococcus
species, so a first-generation cephalosporin, such as cefazolin, is adequate. In clean-contaminated head and neck cases (i.e., any surgical
procedure involving the oropharyngeal mucosa), prophylactic antibiotics should cover both aerobic and anaerobic oral flora (such as Streptococcus, Bacteroides, and Peptostreptococcus).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

A 68-year-old female has been admitted to the emergency
room with recurrent Clostridium difficile colitis. Her first
episode of C. difficile colitis was 3 months prior after
receiving clindamycin for a mild episode of cellulitis. Two
months ago, she had a second episode, treated again with full
symptom resolution. On examination, her vital signs are
normal and her abdomen is benign, with only mildly tender
to deep palpation in the right lower quadrant. Laboratory
results are notable for a leukocytosis of 13.4,000 cells per
MCL with 86% neutrophils, mild hypokalemia, and positive
C. difficile stool antigen. An abdominal film shows a colon of
normal caliber. What is the most appropriate treatment for
this patient?
A. Oral metronidazole 500 mg every 8 h for 10 to 14 days
B. Intravenous (IV) metronidazole 500 mg every 8 h for 10
to 14 days
C. Oral vancomycin 125 mg every 6 h for 10 to 14 days
D. Oral vancomycin, in a tapered and pulsed fashion over
approximately 5 to 7 weeks
E. IV vancomycin 125 mg every 6 h for 10 to 14 days
ANSWER: D
COMMENTS: See Question 11.
Ref.: See Question 11
10. The patient in the question above is admitted and started on
antibiotics, but her condition continues to deteriorate
clinically over the next 2 days despite appropriate antibiotic
therapy, probiotics, and supportive treatment. Her white
blood cell (WBC) count continues to rise to 17.8 and
creatinine increases to 1.5 from baseline of 0.8. She has a
low-grade fever and marginal urine output, and her abdomen
becomes distended, tympanic, and tender. An abdominal
obstructive series shows dilation of the entire colon to 10 cm
in diameter without evidence of pneumoperitoneum. Which
of the following is not an acceptable course of action in
treating severe C. difficile colitis?
A. Transitioning from pulsed to standard scheduled oral
vancomycin 125 mg every 6 h with the addition of IV
metronidazole 500 mg every 8 h
B. Transitioning from pulsed to standard scheduled oral
vancomycin 125 mg every 6 h with the addition of oral
fidaxomicin 200 mg every 12 h
C. Subtotal colectomy
D. Diverting loop ileostomy with colonic lavage
E. Metronidazole enemas
ANSWER: E
COMMENTS: See Question 11.
Ref.: See Question 11
11. Which of the following is true regarding the pathophysiology
of C. difficile infection?
A. Antimicrobial agents with activity against C. difficile are
equally as likely to result in C. difficile colitis as those
without activity against C. difficile.
B. A patient’s inability to produce antibody to toxin A is a
significant predictor of recurrent C. difficile infection.
C. Advanced age is not considered a risk factor for development of clinical C. difficile infection.
D. Studies have suggested that gastric acid suppression [i.e.,
use of proton pump inhibitors (PPIs) or H2 blockers] may
be protective against the development of C. difficile
infection.
E. Alcohol-based hand sanitizers are effective in removing
C. difficile spores after contact with an infected patient.
ANSWER: B

A

Recurrent C. difficile colitis is a
growing health problem in the United States. Treatment of an initial
episode can be accomplished with oral or IV metronidazole (500 mg
every 8 h for 10 to 14 days) or oral vancomycin (125 mg every 6 h
for 10 to 14 days). IV vancomycin is never acceptable as a treatment
for C. difficile colitis. More severe initial infections should be treated
with vancomycin rather than metronidazole. For a patient’s first
relapse, if there is no evidence of systemic toxicity, treatment with
the initial antibiotic regimen may be appropriate. Second relapses
and beyond, however, require oral vancomycin in a tapered and
pulsed fashion (see the following chart). Alternatively, fidaxomicin,
a macrolytic antibiotic that is bactericidal against C. difficile, can be
used. With both drugs, probiotics may be added, though their efficacy
is still unclear. Fecal microbiota transplant has also been shown to
be a cost-effective solution for recurrent C. difficile colitis.
For patients developing evidence of systemic toxicity from C.
difficile colitis, more aggressive therapy is required. Depending on
the patient’s clinical stability, multiple avenues of treatment are
available. Scheduled oral vancomycin or fidaxomicin can be given,
with or without IV metronidazole; IV metronidazole may have
enhanced efficacy in patients with evidence of bowel dysmotility.
The duration of antibiotics in severe C. difficile colitis is generally
at least 17 to 24 days (1 week beyond standard treatment). Intracolonic vancomycin administration (i.e., vancomycin enema) is
also an acceptable treatment method; metronidazole enema is not
an accepted treatment, which makes answer E incorrect. Vancomycin enemas are particularly useful in patients who have conditions
preventing oral vancomycin from reaching the colon (i.e., end
ileostomies, severe ileus, colonic dysmotility, etc.). Patients who
are severely ill with toxic megacolon, perforation, uncontrolled
sepsis, or multiorgan failure should be considered operative candidates. The two most accepted surgical procedures are subtotal colectomy and diverting loop ileostomy with colonic lavage followed
by antegrade vancomycin enemas.
The pathogenesis of C. difficile infection rests largely on the
disruption of normal colonic flora by other antibiotics. Those with
inherent activity against C. difficile (i.e., those who have a robust
antibody response to toxin A) are less likely to become clinically
infected. One study reported that patients who did not develop antibodies to toxin A during their initial infection were 48 times as likely
to develop a recurrent infection. Advanced age (>65 years) is predictive of both initial and recurrent infection. Additional patient-specific
risk factors for infection include gastric acid suppression (either via
PPIs or H2 blockers), recent gastrointestinal surgery, chemotherapy,
stem cell transplant, and obesity. The three classes of antibiotics cited
most frequently as causative agents are clindamycin, cephalosporins,
and fluoroquinolones, and these agents are generally administered
weeks to several months prior to the development of C. difficile
infection. Concomitant use of multiple antibiotics and prolonged
courses of antibiotics have also been found to be risk factors for
infection; however, not all patients who are exposed to C. difficile
and receive antibiotics develop an infection.
Infection control policies are paramount to controlling the
nosocomial spread of C. difficile infection; patients with active
infections should be placed on contact precautions, and all health 60 SECTION I / Surgical Fundamentals
care workers (HCWs) who encounter the patient should wash their
hands with soap and water since C. difficile spores are resistant to
alcohol-based hand sanitizers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which of the following is true regarding postoperative fever?
A. Urinalysis, urine culture, and chest x-ray must be
obtained as part of a complete fever workup in postoperative patients within 72 h of operation.
B. In a febrile postoperative patient, wound cultures should
be obtained regardless of the appearance of the wound.
C. Wound infections in the first 24 to 48 h are uncommon
but, if present, are worrisome for group A streptococcal
or clostridial infection.
D. Fevers persisting for greater than 96 h postoperatively are
expected in cases of diffuse intraabdominal infection,
such as feculent peritonitis from diverticulitis, even with
appropriate surgical management.
E. All of the above.

A

ANSWER: C
COMMENTS: Fever is a common postsurgical finding, but not all
fevers require evaluation. In the first 72 h after surgery, fever is
more likely related to postoperative inflammatory responses in the
host, rather than infection, when the patient is otherwise asymptomatic or without an indwelling urinary catheter. While fever is
expected in postoperative patients with evidence of diffuse infection preoperatively (such as large abscesses, purulent or feculent
peritonitis, or necrotizing soft tissue infection), fevers that are persistent for greater than 96 h after appropriate surgical management,
or recurrent fevers after 96 h, are concerning for recurrent or incompletely cleared infection. Fevers presenting greater than 96 h postoperatively are more likely to be due to infection. Surgical wounds
should only be cultured if there are signs or symptoms suggestive
of wound infection (i.e., purulence, tenderness, and erythema). SSIs
are most commonly due to the native flora of the organ that was
operated upon, but within the first 24 to 48 h of surgery, wound
infections are more likely to be due to group A Streptococcus
(GAS) or Clostridia, which are significantly more virulent organisms. Deep venous thrombosis, pulmonary embolism, and superficial thrombophlebitis are other possible etiologies that should be
considered in the evaluation of a febrile postoperative patient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A 25-year-old male remains nasotracheally intubated in the ICU
while undergoing repeated debridements for Ludwig’s angina.
His infection appears to be adequately drained, although he still
has persistent facial swelling. Sinusitis is expected. Which of the
following is true regarding sinusitis in critically ill patients?
A. The most important risk factor for sinusitis in critically ill
patients is a history of MRSA of the nares.
B. Few sinus infections are polymicrobial; often, only one
organism is isolated in culture.
C. The most commonly isolated organism in sinusitis
cultures is coagulase-negative S. aureus.
D. Computed tomography (CT) scan of the sinuses is the
most sensitive diagnostic imaging modality for sinusitis.
E. Incidence of acute sinusitis in nasotracheally intubated
patients is approximately 75% after 1 week.
ANSWER:

A

COMMENTS: Sinusitis is an infrequent but potentially life-threatening cause of fever in critically ill patients. When the ostia of the
sinuses become obstructed (e.g., from nasotracheal intubation,
nasogastric tube placement, or maxillofacial trauma), bacterial
overgrowth can occur, and when drainage is impaired, infection
results; approximately one-third of patients who are nasotracheally
intubated develop sinusitis within 1 week. The diagnosis is suggested by clinical findings, including cough, purulent nasal discharge, tooth pain, fever, wheezing, or throat or tooth pain. Normal
nasopharyngeal organisms are the most common causes, and infections are often polymicrobial. GNRs are present in approximately
two-third of cases of acute sinusitis in critically ill patients; grampositive rods are isolated in approximately one-third of cases, and
fungi are found in 5%–10%. A CT scan of the sinuses is the most
sensitive imaging modality for diagnosing sinusitis, although plain
films can be obtained as well. Plain films are less sensitive than CT
scan, but the accuracy of plain films in diagnosis can be augmented
if combined with the findings of nasal endoscopy, when performed
by a skilled endoscopist. Needle aspiration of the sinuses to obtain
fluid for cultures provides a definitive diagnosis, but a biopsy may
be required to rule out invasive fungal sinusitis in immunocompromised patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A 24-year-old male presents to the emergency department
after sustaining a puncture wound to his left foot 60 min
prior to presentation. On examination, he has a small metal
nail protruding from the plantar aspect of his left foot, with
moderate surrounding erythema and a small amount of
bleeding, but no significant purulence. He is unsure of his
tetanus vaccination status. How should the issue of potential
tetanus infection be addressed in this patient?
A. Local wound care only
B. Local wound care, IV metronidazole or penicillin for 7 to
10 days
C. Local wound care, IV metronidazole or penicillin for 7 to
10 days, tetanus toxoid
D. Local wound care, IV metronidazole or penicillin for 7 to
10 days, tetanus toxoid, tetanus immunoglobulin
E. No treatment
ANSWER: D
COMMENTS: See Question 15.
Ref.: See Question 15
15. Which of the following is true regarding tetanus infection?
A. Tetanus is caused by tetanus toxin, which is produced by
C. tetani, an aerobic gram-positive bacillus.
B. Tetanus infection has purely motor neuron effects.
C. Tetanus-prone wounds include contaminated wounds (i.e.,
soil, saliva, and stool), crush wounds, or burn wounds.CHAPTER 5 / Surgical Infection and Transmissible Diseases and Surgeons 61
D. Tetanus immunoglobulin is indicated in any patient with
an unknown tetanus vaccination history.
E. None of the above

A

ANSWER: C
COMMENTS: Tetanus toxin, produced by C. tetani, an anaerobic gram-positive bacillus, causes disinhibition of lower motor
neurons; it is taken up via lower motor neurons and transported
proximally to the spinal cord and brainstem and then into inhibitory neurons, causing a functional denervation of motor neurons.
This can result in lockjaw; muscle rigidity; and spasm of respiratory, laryngeal, and abdominal muscles, causing respiratory
failure. Autonomic dysfunction can also be seen with tetanus,
manifesting as labile blood pressure and heart rate. Tetanusprone wounds include contaminated wounds (i.e., soil, saliva,
and stool), crush wounds, or burn wounds. Treatment of tetanusprone wounds includes local wound care (i.e., debridement and
irrigation) and antibiotic therapy targeted against C. tetani.
Depending on the completeness of a patient’s tetanus vaccination, additional therapy is required, based on the following
tables:
Tetanus-Prone Wounds
Previous Tetanus
Toxoid
Administration Tetanus Toxoid
Tetanus
Immunoglobulin
Less than three doses Yes Yes
Three or more doses No; yes, if the last
dose was prior to
more than 5 years
No
Clean Wounds
Previous Tetanus
Toxoid
Administration Tetanus Toxoid
Tetanus
Immunoglobulin
Less than three doses Yes No
Three or more doses No; yes, if the last
dose was prior to
more than 10 years
No
Tetanus immunoglobulin serves to bind tetanus toxin in the
bloodstream to minimize absorption into motor neurons. Muscle
spasm and rigidity should be treated if present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A 62-year-old man with a history of chronic pancreatitis from
alcohol abuse presents to the emergency department with
complaints of fevers and abdominal pain. On examination, he
is febrile to 100.8°F. He is jaundiced and has right upper
quadrant tenderness. His liver enzymes are elevated with a
new leukocytosis. A CT scan of the abdomen demonstrates
cirrhotic liver morphology, calcifications along the pancreas,
and a rim-enhancing hypoechoic liver lesion. Which of the
following is true regarding the diagnosis of a pyogenic liver
abscess (PLA)?
A. Most PLAs are found in the left hepatic lobe.
B. The most common etiology of PLAs is seeding from
another intraabdominal infection via the portal vein.
C. Most PLAs are polymicrobial, and in the United States,
E. coli is the most commonly isolated organism.
D. Percutaneous drainage is recommended for all PLAs if
the drainage is technically feasible.
E. The classic triad of fever, right upper quadrant pain, and
malaise is present in many patients with PLAs.

A

ANSWER: C
COMMENTS: PLAs are relatively uncommon and have vague
presenting symptoms. The classic triad of fever, right upper quadrant pain, and malaise is present in only about one-third of patients.
PLAs have multiple causes including biliary tract disease causing
obstruction, seeding from another intraabdominal infection via the
portal vein, hepatic artery seeding or bacteremia, direct extension
from an adjacent infection (such as cholecystitis and perinephric
abscess), or trauma; a small percentage of cases are cryptogenic.
Biliary tract disease is now the most common etiology of PLAs and
includes cases of choledocholithiasis, biliary stricture, congenital
anomalies of the biliary tree such as choledochal cysts, and obstructing tumors like cholangiocarcinoma or pancreatic adenocarcinoma.
Most infections are polymicrobial, and E. coli is the most frequently isolated organism in the United States, followed by Klebsiella pneumoniae. PLAs occur most frequently in the right lobe of
the liver, given its greater portal venous flow. Treatment involves
broad-spectrum antibiotics (though particularly targeted against
enteric GNRs and anaerobes) with percutaneous drainage for
patients who do not improve with 2 to 3 days of appropriate antimicrobial therapy, abscesses greater than 5 cm in diameter, or
abscesses at risk of rupture. Surgical intervention is generally
reserved for ruptured abscesses, failed response to percutaneous
drainage, uncorrected primary pathology (e.g., biliary stricture), or
multiloculated abscesses not amenable to percutaneous drainage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A 47-year-old man has been admitted to the burn ICU for 4
days after sustaining a 30% total body surface area (TBSA)
burn, involving the neck, chest, bilateral upper extremities,
and lower extremities, when he begins to clinically decompensate. Which of the following is suggestive or diagnostic
of a burn wound sepsis?
A. Conversion of a partial-thickness burn to a full-thickness
burn
B. Fevers greater than 100.4°F
C. Burn wound culture swab growing greater than 105
organisms per gram of tissue swabbed
D. Inability to tolerate enteral tube feeds for greater than
24 h
E. Failure to improve with broad-spectrum antibiotic
administration

A

ANSWER: A
COMMENTS: Burn wound infections remain a major cause of
morbidity and mortality in burn patients, especially in those with
greater than 20% TBSA burns. Burn wounds have a greater propensity for infection than the healthy tissue since the wound lacks
a barrier to environmental organisms, and devascularized burn
tissue provides a protein-rich medium in which bacteria can thrive;
in addition, burns cause significant systemic responses that inhibit
a patient’s normal host defense and healing mechanisms. Most
burns are colonized with bacteria early after injury but do not cause
systemic symptoms. Topical antimicrobials help to reduce the rate
of conversion into invasive wound infections; however, invasive 62 SECTION I / Surgical Fundamentals
infections do result in systemic symptoms and must be treated.
Diagnosis of a burn wound infection requires positive histopathology: the burn must be biopsied, with the growth of >105 organisms
per gram of burn wound tissue. Burn wound infections often manifest with physical changes in the appearance of the burn, such as
conversion to a greater degree of burn and surrounding cellulitis.
Because most burn patients exhibit the signs of a systemic inflammatory response syndrome (SIRS), the American Burn Association
has developed criteria for specifically diagnosing burn wound
sepsis:

• At least one of the following:
• Culture-positive infection (i.e., blood, urine, wound)
• Pathologic tissue source identified (>105 bacteria per gram
of tissue on quantitative biopsy)
• Clinical improvement with antimicrobial therapy
• At least three of the following:
• Temperature greater than 102.2°F or less than 97.7°F
• Progressive tachycardia
• Progressive tachypnea
• Thrombocytopenia that occurs greater than 3 days after
initial resuscitation
• Refractory hypotension
• Leukocytosis > 12,000 or <4000 WBCs/cells MCL
• Hyperglycemia
• Inability to tolerate enteral feedings for >24 h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
. Which of the following is not a classical clinical manifestation of GAS infection?
A. Necrotizing soft tissue infection
B. Acute rheumatic fever
C. Toxic shock syndrome
D. Pharyngitis
E. Meningitis
A

ANSWER: E
COMMENTS: GAS, or group A S. pyogenes, is an aerobic
gram-positive coccus that is responsible for a wide range of clinical illnesses, accounting for greater than 600 million infections
globally each year. The infections caused by GAS vary in clinical
severity, from mild cellulitis to life-threatening toxic shock syndrome, as demonstrated by the answer choices above. GAS is
also responsible for a variety of postinfectious immune-mediated
diseases, such as acute rheumatic fever or poststreptococcal glomerulonephritis. All the answer choices above can be classically
attributed to GAS infection except for meningitis, which is more
commonly caused by group B Streptococcus, particularly in
newborns.
GAS, which colonizes epithelial surfaces, is almost universally sensitive to penicillin. Its main virulence factor is the M
protein, which is a surface antigen and virulence factor encoded by
the emm gene, of which there are over 200 types. Different emm
types are associated with different types of infection; some are
known to cause cutaneous infection, while others cause invasive
infection. The prevalence of different emm types is also socioeconomically distinct, with certain emm types being seen in more
industrialized areas compared with other types being prevalent in
more rural communities. Geography plays a role as well, with variability in the prevalence of emm types based on region.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A 45-year-old man who underwent a splenectomy for
immune thrombocytopenic purpura develops a fever. Which
of the following is true regarding postsplenectomy sepsis?
A. A fever without other localizing symptoms of infection
(such as cough and diarrhea) is usually not worrisome in
postsplenectomy patients.
B. Postsplenectomy sepsis is almost never seen in patients
who complete the appropriate vaccinations.
C. The most common organism implicated in postsplenectomy sepsis is Haemophilus influenzae.
D. Initiation of empiric antibiotics should be delayed until
cultures are obtained.
E. Ceftriaxone and vancomycin are an appropriate empiric
antibiotic regimen in an asplenic patient with fever.

  1. Which of the following statements regarding the risk for
    postsplenectomy sepsis is true?
    A. The indication for splenectomy has no bearing on a
    patient’s risk for developing postsplenectomy sepsis.
    B. Adult splenectomy patients have a greater likelihood of
    developing postsplenectomy sepsis than do children or
    newborns who require a splenectomy.
    C. The risk for postsplenectomy sepsis is highest in the first
    year after splenectomy, but asplenic patients’ increased
    risk for developing sepsis persists for approximately 10
    years following splenectomy.
    D. The risk of sepsis is increased in splenectomy patients
    due to impaired cellular immunity.
    E. None of the above.
A

ANSWER: E
ANSWER: C
COMMENTS: Asplenic patients (those who have either undergone splenectomy or are functionally asplenic, such as in sickle cell
disease) are at an increased risk for a fulminant and potentially
rapidly fatal overwhelming bloodstream infection caused by encapsulated organisms. This is due to impaired bacterial clearance,
especially of encapsulated organisms (i.e., S. pneumoniae, Neisseria meningitidis, and H. influenzae), and impaired humoral (not
cellular) immunity. The risk of developing postsplenectomy sepsis
varies based on the indications for splenectomy, the age at which
the patient underwent splenectomy (or became functionally
asplenic), and the time interval since splenectomy (or functional
asplenia). In terms of indication for splenectomy, patients who have
undergone splenectomy for trauma are at the lowest risk; those who
have undergone splenectomy for hereditary spherocytosis or
immune thrombocytopenic purpura are at intermediate risk; and the
greatest risk patients are those who are functionally asplenic due
to α-thalassemia, sickle cell disease, or portal hypertension. Children (especially those under the age of 5 years) are at a greater risk
for developing sepsis than are adults, but this may also be confounded by the indications for splenectomy or functional asplenia
in this age group. Overall, the risk for postsplenectomy sepsis is
greatest in the first year following splenectomy, but patients who
have undergone splenectomy are at an increased risk for sepsis for
approximately 10 years following surgery.CHAPTER 5 / Surgical Infection and Transmissible Diseases and Surgeons 63
Since the year 2000, when universal vaccination with the
heptavalent pneumococcal conjugate vaccine (PCV7) in children
began, the rates of invasive pneumococcal infection have dropped
significantly, and the rates have continued to fall with the development of the 13-valent vaccine (PCV13) in 2010. Patients who
undergo splenectomy or are functionally asplenic should receive
vaccinations for the encapsulated organisms prior to splenectomy
if it is elective or prior to discharge if performed urgently.
Treatment of postsplenectomy sepsis should be rapid. A fever
in any postsplenectomy patient should prompt initiation of antimicrobial therapy as it may be the only sign of an impending fulminant infection. Postsplenectomy patients, even those who have
undergone vaccination for S. pneumoniae, N. meningitidis, and H.
influenzae, should be counseled to seek medical attention with any
febrile episode. The most common causative organism is S. pneumoniae, so ceftriaxone, which is also active against H. influenzae
and N. meningitidis, is appropriate. Vancomycin should be administered as well due to concerns for penicillin-resistant pneumococcus and β-lactamase–producing H. influenzae. Antibiotics should
be administered immediately and should not be delayed to obtain
cultures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A patient with a recurrent duodenal ulcer is referred for
surgical consultation. He has been having abdominal pain for
the last 2 years. Fifteen months ago, upper endoscopy
showed a duodenal ulcer. The patient was treated with
ranitidine, and his condition improved, but the symptoms
recurred. Upper endoscopy confirmed a recurrent ulcer, and
the result of a Campylobacter-like organism (CLO) test was
positive. The patient was treated with a combination of two
antibiotics and a PPI for 2 weeks. Which of the following
tests best assesses eradication of Helicobacter pylori after
completion of treatment?
A. Urea breath test
B. CLO test
C. Biopsy and culture
D. Serum antibody [by enzyme-linked immunosorbent assay
(ELISA)]
E. Stool antibody test

A

ANSWER: A
COMMENTS: Surgery for the treatment of peptic ulcers is indicated only in the following circumstances: intractable hemorrhage,
perforation, and obstruction. The patient does not have any of these
conditions. Furthermore, H. pylori infection, the most important
pathophysiologic factor in the development of duodenal ulcer, was
never adequately treated. Treatment options for H. pylori infection
are numerous, but they must always include an H2 blocker or a PPI
plus at least two antibiotics. The antibiotics most commonly used
are amoxicillin, clarithromycin, and metronidazole. Bismuth-containing regimens have also been used. Depending on the combination used, the length of treatment varies from 2 to 4 weeks.
Methods of detecting H. pylori can be divided into two categories: invasive and noninvasive. Biopsy and the CLO test require
endoscopy, but all the other tests do not. Like the CLO test, the
urea breath test takes advantage of the ability of H. pylori to split
urea. However, the urea breath test only requires the patient to
“blow,” whereas the CLO test is conducted on a piece of tissue.
The serologic test for H. pylori antibody is useful but of limited
value in determining the success of the therapy. There is no stool
“antibody” test for H. pylori, but a stool antigen test is available
and is as sensitive as the urea breath test.
Since there is no need for repeated endoscopy in this patient,
the clinician must consider the relative merits of the noninvasive
methods. Because antibody test results may remain positive after
treatment, the best choice is the urea breath test, which helps determine the presence of live H. pylori.

17
Q

Which of the following statements regarding anaerobic
bacterial infections is true?
A. Anaerobic bacteria are normal inhabitants of the skin and
mucous membranes.
B. Bacteroides spp. are the most common isolates in
intraabdominal anaerobic infections.
C. If appropriate cultures are obtained, anaerobes are found
in more than 75% of intraabdominal abscesses.
D. Proper treatment of anaerobic infections consists of
surgical drainage, debridement of necrotic tissue, and
appropriate antibiotic therapy.
E. All of the above

A

NSWER: E
COMMENTS: Anaerobic bacteria are normal inhabitants of the skin,
mucous membranes, and gastrointestinal tract. In fact, anaerobic bacteria outnumber aerobic organisms by more than 10:1 in the oral cavity
and by more than 1000:1 in the colon. Therefore it is not surprising
that anaerobes are cultured from up to 90% of intraabdominal abscesses.
The most common pathogens in this group are Bacteroides spp. Bacteroides fragilis is an important copathogen in the pathogenesis of
intraabdominal abscesses. As with most serious infections, proper
treatment involves appropriate drainage of abscesses and debridement
of devitalized tissue when present, as well as appropriate antibiotic
therapy. Antibiotics with excellent broad-spectrum anaerobic activity
include the carbapenems (imipenem, meropenem, and ertapenem),
â-lactam/â-lactamase combinations (ampicillin/sulbactam, ticarcillin/
clavulanate, and piperacillin/tazobactam), and metronidazole. Although
the second-generation cephalosporins (i.e., cefoxitin and cefotetan) and
clindamycin also provide anaerobic coverage, over the past decade an
increase in resistance of Bacteroides organisms to these agents has
been observed. For example, as many as 30% of B. fragilis isolates are
resistant to clindamycin.

18
Q

Which of the following clinical situations or laboratory
results requires systemic antifungal therapy?
A. A single positive blood culture result obtained from an
indwelling intravascular catheter
B. Candida identified from a drain
C. Oral candidiasis
D. Candida isolated from a drain culture in a patient who
recently underwent surgery for colonic perforation
E. Mucocutaneous candidiasis

A

ANSWER: A
COMMENTS: Candidemia is associated with significant morbidity (e.g., endocarditis, septic arthritis, and ophthalmitis) and mortality (approximately 40%). Management of candidemia,
particularly in patients with intravascular devices, remains 64 SECTION I / Surgical Fundamentals
controversial. Although the bloodstream in some patients—usually
those who are immunocompetent—spontaneously clears after
removal of the intravascular device, other patients—particularly
those who are immunosuppressed—have disseminated disease
and require systemic antifungal therapy. There are no accurate
diagnostic tests or methods for selecting high-risk patients to
determine those who require systemic antifungal therapy. Therefore all patients with at least one positive blood culture result for
Candida should be treated with an antifungal agent. All nonsurgically implanted lines should be removed, and if continued central
venous access is required, a new line should be placed at a new
site (not exchanged over a guidewire). Some would attempt to
sterilize the bloodstream without the removal of tunneled catheters
or subcutaneous ports. However, in patients with persistent candidemia or septic shock, these devices should also be removed.
Amphotericin B and fluconazole appear to have similar efficacy
in the treatment of candidemia. Voriconazole and caspofungin are
new antifungal agents that are also effective against Candida.
These agents may be particularly useful for non-albicans species
such as Candida krusei or Candida glabrata, which are less susceptible to fluconazole. All patients with candidemia should be
evaluated for manifestations of disseminated disease, such as
ocular involvement or OM. Candida identified from a surgical
drain most likely represents colonization and does not require
systemic antifungal therapy. Mucocutaneous candidiasis can be
treated with local nystatin or clotrimazole.

19
Q

A 10-year-old boy who recently emigrated from Mexico has had
a 2-day illness characterized by fever, odynophagia, dysphagia,
and drooling at the mouth. Physical examination reveals the
child to be in a toxic condition with a temperature of 102°F
(38.9°C), tachycardia, and tachypnea. There is mild tenderness
in the submandibular area and few palpable lymph nodes. The
suspected diagnosis is epiglottitis, which is confirmed with a CT
scan of the neck. Blood culture results are positive. What kind
of organism will probably be seen on Gram stain?
A. Gram-positive cocci in pairs and chains
B. Gram-positive cocci in clusters
C. Slender GNRs
D. Gram-negative coccobacilli
E. Spirochetes

A

ANSWER: D
COMMENTS: The patient has acute epiglottitis, most likely
attributable to H. influenzae type B, which is recovered from the
blood in up to 100% of cases. Classically, the patient is a 2- to
4-year-old boy with a short history of fever, irritability, dysphonia,
and dysphagia, which can occur at any time of the year. The widespread use of H. influenzae type B vaccine in developed countries
has led to a marked decline in invasive disease with this organism.
However, the disease is still common in developing countries.
Haemophilus species are gram-negative coccobacilli. Treatment
includes early intubation, with plans for a cricothyroidotomy or a
tracheotomy if intubation fails, and an antibiotic such as ceftriaxone
or ampicillin/sulbactam

20
Q

Which of the following previously healthy patients scheduled
for an operation should undergo human immunodeficiency
virus (HIV) antibody testing?
A. A 35-year-old man seen for removal of a lipoma in the
anterior triangle of the neck. A routine preoperative
complete blood count reveals a WBC count of 4500 cells/
mL with a normal differential, hemoglobin level of 13 g/
dL, and platelet count of 81,000/mL
B. A 40-year-old man seen for repair of an inguinal hernia.
Physical examination reveals white, adherent, nonremovable plaques on the lateral aspect of his tongue
C. A 28-year-old woman seen for the removal of a breast
lump in whom a painful vesicular rash along the T8-10
dermatomes develops on the right side
D. A 20-year-old man undergoing nephrectomy for living
related-donor transplantation
E. All of the above

A

ANSWER: E
COMMENTS: Several risk groups have been identified in whom
HIV testing is indicated, including persons with sexually transmitted diseases and persons in high-risk categories, such as injected
drug users, homosexual and bisexual men, hemophiliacs, patients
with active tuberculosis (TB), and pregnant women. Donors of
blood or organs should be tested. Certain clinical or laboratory
findings should also prompt HIV testing. Such findings include
idiopathic thrombocytopenia, oral hairy leukoplakia, reactivation
varicella-zoster virus infection involving more than one dermatome, unexplained oral candidiasis, persistent vulvovaginal candidiasis, and herpes simplex virus infection resistant to treatment.

21
Q

Which of the following is true regarding the management of
hepatic echinococcal disease?
A. Preoperative endoscopic retrograde cholangiopancreatography can be both diagnostic and therapeutic for cyst–biliary
communication.
B. Percutaneous drainage of hydatid cysts is contraindicated
due to the risk for anaphylaxis.
C. Surgical excision of hydatid cysts need not be preceded
by antiparasitic chemotherapy.
D. CT scan is the most sensitive imaging modality to
identify communication between hydatid cysts and the
biliary tree.
E. Praziquantel is the preferred antiparasitic agent in hydatid
cyst disease

A

ANSWER: A
COMMENTS: Hydatid cyst disease is caused by Echinococcus,
with E. multilocularis and E. granulosus being the most common
species causing infection in humans. The definitive hosts of these
parasites are dogs, and the intermediate hosts are most commonly
sheep or goats; humans are incidental hosts.
Albendazole is the preferred antiparasitic therapy for Echinococcus. Mebendazole is also an option, although it has less in vitro
activity than albendazole. Benzimidazole agents interfere with
parasite glucose absorption.
The goals of drainage procedures, either surgical or percutaneous, for hepatic echinococcal cysts are inactivation of the parasites
and evacuation and obliteration of the cyst cavity; surgical procedures also include the removal of the germinal layer of the cyst
cavity. Radical surgical procedures, such as pericystectomy, partial
hepatectomy, or lobectomy, are preferred over less invasive CHAPTER 5 / Surgical Infection and Transmissible Diseases and Surgeons 65
surgical techniques. PAIR (puncture, aspiration of the cyst, injection of a scolicidal solution such as hypertonic saline, and reaspiration of cyst contents) is generally the preferred percutaneous
drainage procedure. Any drainage procedure should be preceded by
the use of a benzimidazole (i.e., albendazole or mebendazole) to
sterilize the cyst contents and reduce the risk of anaphylaxis and
echinococcal dissemination.
Cystobiliary communication is likely relatively common in
hepatic echinococcal disease, but the majority of cases are not
clinically apparent. Magnetic resonance cholangiopancreatography
has a sensitivity of 92% in diagnosing intrabiliary rupture, whereas
CT scan has only 75% sensitivity. Endoscopic retrograde cholangiopancreatography (ERCP) is also very sensitive (86%–100%)
and can be used for therapeutic intervention. ERCP with sphincterotomy effectively treats cholangitis related to cystobiliary communication, and some studies have shown that it can decrease the
rate of postoperative biliary fistula formation.

22
Q

A diabetic patient has recently been discharged from the
hospital after intracranial bleeding. He is readmitted for
aspiration pneumonia. His condition deteriorates rapidly,
with hypotension and multiorgan dysfunction. Which of the
following treatments is contraindicated?
A. Volume resuscitation
B. Antibiotics
C. Activated protein C
D. Intensive insulin therapy for hyperglycemia
E. Low-dose hydrocortisone

A

ANSWER: C
COMMENTS: Severe sepsis is characterized by multiorgan dysfunction with or without shock and is due to a generalized inflammatory
and procoagulant response to infection. Efforts to improve the outcome
with anticytokine therapy along with antibiotics and supportive care
have until recently not been associated with improved survival.
Recently, a randomized, double-blind, placebo-controlled multicenter
trial evaluating recombinant activated protein C has demonstrated a
survival benefit in patients with severe sepsis. However, activated
protein C treatment was associated with an increased risk for bleeding
and is contraindicated in patients with recent hemorrhagic stroke. Fluid
resuscitation and antibiotics are mainstays in the treatment of sepsis.
Intensive insulin therapy that maintains serum glucose levels at 80 to
110 mg/dL reduces morbidity and mortality in critically ill patients.
The mechanism is unknown, but it is possible that correcting hyperglycemia may improve neutrophil function. The use of corticosteroids
for sepsis remains controversial. High doses of corticosteroids may in
fact worsen outcomes by increasing the frequency of secondary infections. However, low doses of corticosteroids may be beneficial in
septic patients who may have “relative” adrenal insufficiency despite
elevated levels of circulating cortisol. Although the issue is controversial, the use of low-dose hydrocortisone is not contraindicated in this
patient.

23
Q

Endocarditis prophylaxis is recommended for which of the
following patients?
A. A patient with mitral valve prolapse but without murmur
who is undergoing lithotripsy for renal calculi
B. A patient with a history of rheumatic fever and normal
cardiac valves who is undergoing prostatic biopsy
C. A patient with a prosthetic aortic valve who is undergoing pulmonary resection
D. A patient with severe hypertrophic cardiomyopathy who
is undergoing endoscopic retrograde cholangiography for
biliary obstruction
E. A patient previously treated for streptococcal endocarditis
who is undergoing colonoscopy

A

ANSWER: C
COMMENTS: Antibiotic prophylaxis for endocarditis is recommended for patients with certain cardiac conditions who are undergoing any dental procedure that involves the gingival tissues or
periapical region of a tooth and for any procedure involving perforation of the oral mucosa. In addition, patients undergoing procedures on the respiratory tract or those with skin or soft tissue
infections should also receive prophylaxis. The cardiac conditions
associated with the highest risk for adverse outcomes from infective endocarditis for which prophylaxis is indicated prior to the
previously listed procedures include prosthetic heart valves, history
of infective endocarditis, congenital heart disease (CHD) limited to
unrepaired cyanotic CHD, repaired CHD with prosthetic material
or devices during the first 6 months after the procedure, repaired
CHD with residual defects at the site or adjacent to the site of a
prosthesis, and cardiac transplantation recipients with cardiac valvulopathy. Prophylaxis against viridans group streptococci with a
penicillin, cephalosporin, or clindamycin is recommended. Routine
prophylaxis in patients undergoing gastrointestinal or genitourinary
procedures is no longer recommended

24
Q

A patient is infected with HIV. His last CD4+ T-lymphocyte
count was 50 cells/mm3, and his viral load was 100,000 copies/
mL. He comes to the hospital with a sudden onset of right
hemiparesis. He has been afebrile. A CT scan and magnetic
resonance imaging (MRI) of the brain show multiple ringenhancing lesions in the left cerebral hemisphere. The Toxoplasma IgG antibody test result is positive. He has received
pyrimethamine and sulfadiazine for 12 days. Neurologically, the
patient is stable. Which of the following is the next best step?
A. Repeat MRI of the brain.
B. Continue the same antibiotic therapy for an additional 10
days and reassess.
C. Switch treatment to pyrimethamine with the addition of
clindamycin and reassess whether the patient improves
clinically in 10 to 14 days.
D. Add corticosteroids to the treatment regimen.
E. Perform a positron emission tomography (PET) or
single-photon emission computed tomography (SPECT)
scan.

A

ANSWER: A
COMMENTS: Up to 90% of HIV-infected patients with advanced
disease (<100 CD4+ cells/mm3), multiple ring-enhancing lesions,
and a positive Toxoplasma IgG antibody have cerebral toxoplasmosis. Empiric treatment with pyrimethamine, sulfadiazine, and
folinic acid is recommended. Most patients with central nervous
system (CNS) toxoplasmosis respond rapidly to this therapy, with
nearly 90% of patients demonstrating neurologic improvement at
2 weeks. Radiographic improvement occurs at a slower pace, with
approximately 50% improvement on repeated MRI of the brain 66 SECTION I / Surgical Fundamentals
occurring within 3 weeks of initiating treatment. For patients who
do not improve by 2 weeks, a brain biopsy is indicated. Although
lymphoma is the most likely alternative diagnosis in patients with
acquired immunodeficiency syndrome (AIDS) and CNS lesions, up
to 25% of brain biopsy specimens reveal toxoplasmosis. Thallium-201 (SPECT) or PET scans may provide useful information
in that a “cold” lesion revealed by SPECT or hypometabolic lesions
seen on PET scanning are consistent with infection. However,
false-positive and false-negative results can occur with these functional imaging studies. The addition of corticosteroids may be
useful in the treatment of increased intracranial pressure. However,
this antiinflammatory effect may make interpretation of clinical and
radiographic responses difficult

25
Q

. Match each agent in the left-hand column with one or more
mechanisms of antimicrobial action in the right-hand column.
A. Carbapenems a. Impairment of bacterial DNA synthesis
B. Aminoglycosides b. Inhibition of cell wall synthesis
C. Quinolones c. Disruption of ribosomal protein synthesis
D. Cephalosporins d. Disruption of cell wall cation homeostasis
E. Vancomycin e. Disruption of the cytoplasmic membrane

A

ANSWER: A- a ; B- c , d ; C- a ;
D - b ; E- b
COMMENTS: All the antimicrobial agents listed above are bactericidal agents (i.e., their associated mechanisms of action result in
bacterial death). Bacteriostatic agents (e.g., tetracyclines, chloramphenicol, erythromycin, clindamycin, and linezolid) act by preventing bacterial growth but do not result in bacterial death. They work
primarily through inhibition of ribosomal protein synthesis. Both
carbapenems and cephalosporins are â-lactam antibiotics and hence
have a similar mode of activity. Enzymes located within the bacterial
cytoplasmic membrane are responsible for peptide cross-linkage.
These enzymes are called penicillin-binding proteins (PBPs) and are
the site at which â-lactam drugs bind. Such binding interferes with
bacterial cell wall synthesis and eventually results in cell lysis. Gramnegative bacteria contain a variable number of various PBPs. Each
â-lactam antibiotic has different affinities for the different PBPs.
Vancomycin is a glycopeptide that also inhibits bacterial cell wall
synthesis and assembly. Vancomycin complexes to cell wall precursors and prevents elongation and cross-linkage, thereby making the
cell susceptible to lysis. This antibacterial activity is limited to grampositive organisms. Aminoglycosides bind irreversibly to the 30S
bacterial ribosome and interfere with protein synthesis. For this activity to take place, they must penetrate the cell wall, which occurs
optimally under aerobic conditions. Unlike other antibiotics that
inhibit protein synthesis, aminoglycosides are bactericidal. This
feature is due to their disruptive effect on calcium and magnesium
homeostasis within the cell wall. Quinolones inhibit topoisomerase
II (DNA gyrase) and topoisomerase IV, which impairs DNA synthesis in bacteria. Appreciation of the mechanism of action of antimicrobials may have a bearing on the selection of alternative therapies
when bacterial resistance to the drug of choice develops.

26
Q

Which of the following statements regarding diabetic foot
infections is false?
A. Acute diabetic foot infections are often caused by
gram-positive organisms.
B. Chronic diabetic foot infections are polymicrobial.
C. To diagnose an infection in a patient with a chronic
wound, a foul odor and redness must be present.
D. MRSA infections are associated with a worse outcome.
E. Impaired host defenses allow low-virulence colonizers
such as coagulase-negative staphylococci and Corynebacterium spp. to become pathogens.

Ref.: See Question 32
32. Which of the following regarding the treatment of diabetic
foot infections is true?
A. Acute diabetic foot infections are caused by monomicrobial gram-negative aerobes.
B. The use of antibiotics for an uninfected chronic wound
facilitates wound closure and prevents future infection.
C. Sharp debridement of necrotic or unhealthy tissue prolongs
wound healing and removes a potential reservoir for
bacteria.
D. Avoiding direct pressure on the wound facilitates healing.
E. The administration of granulocyte-stimulating factors
(GSFs) results in faster resolution of the infection.

A

ANSWER: C
COMMENTS: See Question 32.
ANSWER: D
COMMENTS: Diabetic patients have a higher risk for foot infections because of factors such as vascular insufficiency, decreased
sensation, hyperglycemia, and impairment of the immune system,
particularly neutrophil dysfunction. Deep tissue biopsy of the
infected foot is the preferred method of culture. Acute diabetic foot
infections are often caused by monomicrobial aerobic gram-positive cocci (S. aureus and â-hemolytic streptococci, especially group
B), whereas patients with chronic wounds and those who have
recently received antibiotic therapy generally have polymicrobial
gram-positive and gram-negative aerobes and anaerobes within
their wound, including enterococci, Enterobacter, obligate anaerobes, and P. aeruginosa. Initial therapy is usually empiric and based
on the severity of infection and available microbiology data (culture
results or Gram stain). A majority of mild infections can be treated
with orally dosed antimicrobials directed against aerobic grampositive cocci. In patients with more severe infections or extensive
chronic infections, parenteral broad-spectrum antibiotics with
activity against gram-positive cocci (including MRSA) and gramnegative and obligate anaerobic organisms are warranted. The diagnosis of infection in patients with chronic wounds includes the
presence of purulent secretions (pus) and two or more of the following: redness, warmth, swelling or induration, and pain or tenderness. MRSA infections are associated with worse outcomes, and
impaired host defenses allow low-virulence colonizers such as
coagulase-negative staphylococci and Corynebacterium spp. to
become pathogens. In addition to antibiotics, early incision and
drainage of abscesses with debridement of devitalized tissue,
immobilization, and supportive care are important in the total management of a diabetic foot. In the presence of significant vascular
insufficiency, revascularization of the distal end of the lower
extremity may improve healing and prevent amputation. Radioactive studies using technetium-99 (bone scan) or gallium citrate or
indium-labeled leukocyte scans have poor specificity and should
not be performed routinely. MRI has become the imaging study of
choice for diagnosing OM.CHAPTER 5 / Surgical Infection and Transmissible Diseases and Surgeons 67
Continued use of antimicrobials is not warranted for the entire
time that the wound is open or for the management of clinically
uninfected ulceration either to enhance wound healing or as prophylaxis against infection. Local wound care with sharp debridement of necrotic or unhealthy tissue promotes wound healing and
removes a potential reservoir of pathogens. Avoiding direct pressure on the wound and providing off-loading devices facilitate
wound healing. Administration of granulocyte colony-stimulating
factors does not accelerate the resolution of infection but may
significantly reduce the need for operative procedures.

27
Q

Match each clinical characteristic or agent in the left-hand
column with the correct infecting organism or organisms in
the right-hand column. More than one answer may apply.
A. Fibrosing mediastinitis a. Candida albicans
B. Amphotericin b. Nocardia asteroides
C. Intertrigo c. Actinomyces israelii
D. Brain abscess d. Cryptococcus neoformans
E. Pelvic mass e. Histoplasma capsulatum

A

ANSWER: A- e ; B- a , d , e ; C- a ;
D - b ; E- c
COMMENTS: Amphotericin B remains an important agent for the
treatment of systemic mycotic infections, including candidiasis,
mucormycosis, cryptococcosis, histoplasmosis, coccidioidomycosis, sporotrichosis, and aspergillosis. Amphotericin B is a fungicidal agent. Binding of amphotericin B to ergosterol in the fungal
cell membrane alters permeability, with leakage of intracellular
ions and macromolecules, leading to cell death. Adverse events
such as infusion reactions and nephrotoxicity are common with the
conventional (deoxycholate) form of the drug. New lipid formulations of amphotericin B have been developed and are associated
with a reduction in toxicity without sacrificing efficacy. Newer
triazoles (voriconazole and posaconazole) and echinocandins
(caspofungin, micafungin, and anidulafungin) are emerging as
alternative broad-spectrum antifungal agents. Histoplasmosis is
predominantly a pulmonary infection caused by Histoplasma capsulatum, a dimorphic fungus endemic to the Mississippi and Ohio
River valleys and along the Appalachian Mountains. Histoplasmosis has been associated with massive enlargement of the mediastinal lymph nodes secondary to granulomatous inflammation. During
the healing process, fibrotic tissue can cause postobstructive pneumonia or constriction of the esophagus or superior vena cava and
result in dysphagia or superior vena cava syndrome (or both).
Actinomycosis is caused by a group of gram-positive higher-order
bacteria that are part of the normal flora found in the oral cavity,
gastrointestinal tract, and female genital tract. Typically, infections
with Actinomyces spp. often occur after disruption of mucosal
surfaces and lead to oral and cervical disease, pneumonia with
empyema, and intraabdominal or pelvic abscesses. Placement of
intrauterine devices has been associated with pelvic abscess secondary to this organism. Sinus tract formation is common as these
organisms extend, unrestricted, through tissue planes. High-dose
penicillin and surgical drainage are generally required for cure.
Nocardia spp., other higher-order bacteria, are found in soil,
organic matter, and water. Human infection occurs after inhalation
or skin inoculation. Chronic pneumonia can occur, usually in
immunocompromised patients. Skin lesions and brain abscesses are
common with a disseminated infection.
Prolonged treatment with sulfonamides in combination with
other antibiotics is required for cure. C. neoformans causes meningitis and pulmonary disease. Infection is common in the setting of
immunodeficiency, such as organ transplantation and AIDS, but it
may also occur in immunocompetent hosts. C. albicans is a
common inhabitant of the mucous membranes and gastrointestinal
tract. Intertrigo is one form of cutaneous candidiasis that occurs in
skinfolds where a warm moist environment exists. Vesiculopustules
develop, enlarge, rupture, and cause maceration and fissuring.
Obese and diabetic patients are at risk for the development of
candidal intertrigo. Local care, including nystatin powder, is usually
effective.

28
Q

Which of the following statements is correct regarding
spontaneous bacterial peritonitis (SBP; primary peritonitis) in
a cirrhotic patient?
A. Infection is usually polymicrobial.
B. Ascitic fluid culture results are always positive.
C. The most likely pathogenic mechanism is translocation
from the gut.
D. Twenty-one days of antibiotic treatment may be adequate.
E. Infection-related mortality has declined to less than 10%

A

ANSWER: E
COMMENTS: SBP is a monomicrobial infection, with enteric
GNRs accounting for 60%–70% of the episodes of SBP. E. coli
is the most frequently recovered pathogen, followed by K. pneumoniae. Streptococcal species, including pneumococci and
enterococci, are also important pathogens. Ascitic fluid culture
results are negative in many cases, but inoculation of blood
culture bottles at the bedside yields bacterial growth in approximately 80% of cases. SBP most likely develops from the combination of prolonged bacteremia secondary to abnormal host
defense, intrahepatic shunting, and impaired bactericidal activity of ascetic fluid. Transmural migration of gut flora and transfallopian spread of vaginal bacteria to the peritoneal space may
also occur. Initial antimicrobial treatment should include coverage against aerobic gram-negative organisms. A third-generation
cephalosporin, such as cefotaxime or ceftriaxone, is a reasonable
choice. The duration of antibiotic treatment is unclear; 2 weeks
has been suggested, but shorter courses (5 days) may have
similar efficacy. Although the in-hospital mortality rate
approaches 40%, infection-related mortality has declined significantly (10%). Unfortunately, the probability of recurrence is
70% at 1 year, with 1- and 2-year survival rates being 30% and
20%, respectively.

29
Q

Which of the following patients with cirrhosis benefit from
prophylactic antibiotic therapy to decrease the risk for SBP?
A. Patients awaiting liver transplantation
B. Patients hospitalized with acute gastrointestinal bleeding
C. Patients with ascitic fluid protein levels of greater than 1
g/100 mL
D. Patients who have recovered from a previous episode of
SBP
E. Patients with ascitic fluid protein levels of less than 1
g/100 mL

A

ANSWER: C
COMMENTS: Randomized trials have demonstrated that secondary
prophylaxis with oral norfloxacin, 400 mg/day, or trimethoprim/sulfamethoxazole, one double-strength tablet five times per week decreases
the risk for recurrent SBP from 68% to 20%. However, overall mortality in these patients remains unchanged compared with those not
receiving secondary prophylaxis. Another observation is that longterm quinolone use has been associated with the development of infection with quinolone-resistant bacteria. In approximately 30%–40% of
patients with cirrhosis hospitalized for acute gastrointestinal bleeding,
infection develops during the hospitalization. Norfloxacin (400 mg a
day for 7 days) decreases the incidence of infective episodes involving
gram-negative bacteria. The risk for SBP increases tenfold in patients
with an ascitic fluid protein concentration of lessthan 1 g/100 mLfluid.
Norfloxacin, 400 mg/day, during hospitalization decreases the incidence of SBP in these patients as well. Patients hospitalized while
awaiting liver transplantation are probably at risk for SBP and may
therefore benefit from antibiotic prophylaxis. Active infection is a
contraindication to liver transplantation.

30
Q

Which of the following statements regarding secondary
peritonitis is false?
A. It usually occurs because of perforation of an intraabdominal viscus.
B. Carbapenems, aminoglycosides, and fourth-generation
cephalosporins have equal efficacy in treatment studies.
C. Increased age, cancer, cirrhosis, and systemic illness are
factors that increase the mortality rate.
D. Sequestration of bacteria within fibrin clots leads to
intraabdominal abscess formation.
E. The most common organism cultured from the abdomen
is E. coli.

A

ANSWER: B
COMMENTS: Secondary peritonitis usually occurs because of perforation of an intraabdominal viscus such as perforated peptic ulcer,
appendix, or diverticulum or penetrating gastrointestinal trauma. The
infection is polymicrobial, with facultative aerobes and anaerobes
acting synergistically. One study revealed an average of 2.5 anaerobes
and 2 facultative aerobes identified per case of secondary peritonitis.
E. coli is the most common isolate in culture. Bacteroides spp. are the
most frequent anaerobes cultured from abdominal infections. About
1012 bacteria reside in the colon per gram of feces, with 90% of these
bacteria being anaerobic organisms. Any process that impairs immunologic function or is associated with general debilitation increases
mortality. Age, cancer, hepatic cirrhosis, and the presence of a systemic
illness have been shown to increase mortality. One of the defense
mechanisms of the peritoneal cavity is the production of fibrin to
sequester bacteria for limiting systemic spread. Such sequestration
leads to the formation of intraabdominal abscesses, which generally
require drainage for cure. Treatment of secondary peritonitis requires
surgical intervention for removal of the source of infection and systemic antibiotics for eradication of residual bacteria. Antibiotics
selected should include agents with broad-spectrum coverage for facultative aerobes, gram-negative bacilli, and anaerobes. Carbapenems
are a good empiric choice for treatment. Aminoglycosides and fourthgeneration cephalosporins lack anaerobic activity.

31
Q

. Which of the following statements regarding cytomegalovirus (CMV) infection and solid organ transplantation is false?
A. Symptomatic infection occurs 2 to 6 months after
transplantation.
B. Patients being treated for acute rejection are at an increased
risk for the development of symptomatic CMV infection.
C. Transmission can occur through the donor organ.
D. Reactivation of latent infection is associated with the
greatest risk for the development of severe disease.
E. CMV infection may be associated with premature
atherosclerosis in cardiac transplant patients

A

ANSWER: D
COMMENTS: CMV is the most important pathogen affecting
recipients of solid organ transplants. Symptomatic CMV disease may
develop in as many as 50% of allograft recipients, usually 2 to 6
months after transplantation. CMV-seronegative recipients who are
primarily infected are at the greatest risk for the development of
severe CMV disease. Primary infection can occur through the donor
organ, unscreened blood products, or intimate contact with a viral
shedder. Reactivation of latent infection is less likely to cause severe
disease. Patients receiving muromonab-CD3 (OKT3)/antilymphocyte globulin (ALG) therapy for acute rejection also appear to be at
risk for the development of CMV disease. In addition to clinical
disease directly attributable to CMV infection, CMV has indirect
immunomodulatory activity. Symptomatic CMV infections are associated with an increased incidence of bacterial infections and opportunistic infections such as aspergillosis and Pneumocystis carinii
pneumonia. In heart transplant patients, acute rejection and accelerated atherosclerosis are associated with CMV infection. Ganciclovir
is the most commonly used agent for the prevention of CMV infection and disease; however, there is growing concern regarding the
emergence of ganciclovir resistance.

32
Q

A 28-year-old man who sustained closed-head trauma in a
motor vehicle accident a month earlier comes to the
emergency department with a 3-day history of progressive
headache, fever, and confusion. His wife reports the recent
onset of clear drainage from his left naris. Physical examination reveals a temperature of 102°F (38.9°C), a stiff neck,
and no rash. Which of the following statements concerning
the patient is true?
A. He most likely has bacterial meningitis secondary to S.
aureus.
B. Antiretroviral prophylaxis has been beneficial in preventing
bacterial meningitis after head trauma.
C. Empiric antibiotics should include an extended-spectrum
cephalosporin and vancomycin.
D. Corticosteroid administration with antibiotics is not indicated.
E. He requires immediate surgical intervention for repair of
cerebrospinal fluid leakage.

A

ANSWER: C
COMMENTS: The patient probably sustained a basilar skull fracture and a dural rent, with subsequent development of a dural fistula
from the subarachnoid space and nasal cavity or paranasal sinuses.
Cerebrospinal fluid rhinorrhea may occur and can easily be diagnosed by detecting the presence of â2-transferrin in nasal CHAPTER 5 / Surgical Infection and Transmissible Diseases and Surgeons 69
secretions. In patients with known basilar skull fracture, cerebrospinal fluid rhinorrhea develops in approximately 10% of the cases.
Of these patients, bacterial meningitis develops in up to 30%. S.
pneumoniae is the most common pathogen (65% of cases). Other
organisms, such as H. influenzae, N. meningitidis, and S. aureus,
account for the remaining cases. Empiric treatment should include
an extended-spectrum cephalosporin (ceftriaxone, cefotaxime, or
cefepime) and vancomycin since the incidence of â-lactam–resistant pneumococci is increasing. Prophylactic antibiotics have no
proven benefit and may predispose to meningitis from antibioticresistant gram-negative bacteria. A recent prospective study demonstrated a survival advantage in patients with pneumococcal
meningitis who received corticosteroids before or at the time of
antibiotic administration. Spontaneous closure of the dural fistula
is less likely in patients with a delayed manifestation of cerebrospinal fluid leakage with meningitis, and surgical repair is indicated. Diagnostic studies to identify the site of the fistula and
treatment of any CNS infection should be completed before surgical intervention

33
Q

Which of the following statements regarding hepatitis C virus
(HCV) infection is false?
A. The prevalence of HCV infection in HCWs is similar to
that in the general population.
B. Chronic HCV infection occurs in 75%–85% of patients
after acute infection.
C. Hepatic failure because of chronic HCV infection is the
most common indication for liver transplantation.
D. Pegylated interferon plus ribavirin is an effective therapy
for most patients with chronic HCV infection.
E. Factors associated with the development of cirrhosis
include male gender, alcohol use, and coinfection with HIV.

A

ANSWER: D
COMMENTS: Persons with acute HCV infection are typically
asymptomatic (60%–70%) or have a mild clinical illness. Fulminant hepatitis is rare. Chronic HCV infection develops in approximately 75%–80% of persons with acute HCV infection. Cirrhosis
develops in 10%–20% of chronically infected individuals, usually
after more than 20 years of infection. Liver failure from chronic
HCV infection has become the leading indication for liver transplantation. Increased alcohol use, male gender, HIV coinfection,
and HCV genotype 1 are associated with more severe liver disease.
Hepatocellular carcinoma can be a late complication in 1%–2% of
patients with cirrhosis. Antiviral therapy is recommended for individuals at an increased risk for progressive liver disease, as demonstrated by persistently elevated serum transaminase levels,
detectable HCV RNA levels, and moderate inflammation in liver
biopsy specimens.
The prevalence of HCV infection is highest in injected drug
users and patients undergoing hemodialysis. Overall, nearly 2% of
the U.S. population has persistent HCV infection. Although transmission of HCV to HCWs occurs after approximately 3% of
needlestick exposures involving HCV-infected patients, the prevalence of HCV infection in HCWs, including surgeons, is like the
general population.

34
Q

Which statement about Mycobacterium tuberculosis treatment
and prophylaxis is true?
A. Two-drug treatment with INH and rifampin (RIF) for 9
months is standard therapy for active pulmonary TB.
B. Treatment failure can be due to drug resistance or
nonadherence.
C. HIV-infected individuals require prolonged therapy for
active TB.
D. INH prophylaxis for latent TB is given for at least 12
months.
E. INH prophylaxis should not be given to individuals
with recent conversion from purified protein derivative
(PPD)-negative to PPD-positive status.

A

ANSWER: B
COMMENTS: Recent Centers for Disease Control and Prevention
(CDC) guidelines recommend that all patients with active pulmonary
TB receive four-drug therapy consisting of INH, RIF, pyrazinamide,
and ethambutol for the initial 2 months of treatment. For patients
with drug-susceptible TB and negative sputum test results after 2
months of therapy, treatment can be completed with 4 months of INH
and RIF. Extrapulmonary disease requires 6 to 9 months of treatment,
except for meningitis, which is treated for 1 year. HIV-infected individuals are treated similar to non–HIV-infected patients with TB.
However, significant drug–drug interactions may occur with antiretroviral agents and TB drugs and may alter therapeutic decisions.
Treatment failures are generally due to nonadherence by patients to
multidrug regimens. Currently, local health departments have directly
observed therapy programs to improve compliance with and completion of anti-TB medication regimens. Another cause of treatment
failure is infection with multidrug-resistant strains of M. tuberculosis.
Conditions associated with a higher rate of resistance include TB in
those known to have a higher prevalence of drug resistance, such as
Asians or Hispanics and previously treated individuals; the persistence of culture-positive sputum after 2 months of therapy; and
known exposure to drug-resistant TB.
Certain individuals are at considerable risk for the development
of active TB once infected (latent TB). TB skin testing (Mantoux/
PPD) is useful for identifying latent TB in high-risk individuals.
Three cut points have been recommended for defining a positive
tuberculin reaction: greater than 5 mm, greater than 10 mm, and
greater than 15 mm of induration. Persons considered at highest risk
(>5 mm of induration) include individuals with HIV infection, recent
contacts with TB patients, and organ transplant patients. Individuals
also at risk (>10-mm induration) include injectable drug users, residents of nursing homes and prisons, hospital employees, and recent
immigrants from countries with a high prevalence of TB. These
individuals, who are at a considerable risk for the development of
active TB once infected, should receive 9 months of INH therapy.

35
Q

Which of the following is true regarding the bacteriology of
vascular graft infections?
A. S. epidermidis is the most commonly isolated organism.
B. Fungal graft infections are uncommon, but when they do
occur, they are most common in immunocompromised
patients.
C. Gram-negative organisms are implicated most frequently
in thoracic aortic and carotid artery graft infections.
D. Gram-negative infections are often less virulent and have
fewer major complications than do gram-positive infections.
E. None of the above.

  1. Which of the following clinical scenarios raises concern for
    vascular graft infection?
    A. New-onset gastrointestinal bleeding in a patient with a
    history of abdominal aortic endograft placement
    B. The presence of a draining sinus tract 3 cm distal to a
    forearm arteriovenous graft for hemodialysis
    C. A slowly growing pulsatile mass in the groin of a patient
    with a history of an aortofemoral bypass graft
    D. CT scan demonstrating the presence of a fluid collection
    adjacent to an abdominal aortic graft
    E. All of the above
A

ANSWER: B
COMMENTS: See Question 42.
Ref.: See Question 42

ANSWER: E
COMMENTS: Vascular graft infections can manifest in a variety of
ways, and surgeons must maintain a high index of suspicion for graft
infection. There are multiple mechanisms by which vascular grafts
can become infected: perioperative contamination (including from
lymphatic disruption), seeding from bacteremia, contiguous spread
from an adjacent infectious process, and erosion of the graft into the
gastrointestinal or genitourinary tracts. Grafts are more prone to
infection than natural tissue since bacteria adhere to graft material
and form a biofilm that resists the body’s natural immunologic
defenses. The most likely organisms in vascular graft infections are
gram-positive cocci such as S. aureus (the most common pathogen)
and S. epidermidis, but the incidence of GNR infections is significantly increased in abdominal aortic, aortofemoral, and infrainguinal
vascular graft infections. Gram-negative infections are more virulent
than gram-positive infections, because gram-negative organisms
produce proteases, elastases, and other destructive enzymes, which
can cause anastomotic disruption and vessel rupture. In the vast
majority of cases of vascular graft infection, the prosthetic material
must be excised for complete eradication of the infection

36
Q

Suspicion of OM in a diabetic foot ulcer should be raised in
all of the following except:
A. A deep ulcer that overlies a bony prominence
B. An ulcer that does not heal after 2 weeks of appropriate
therapy
C. A patient with a swollen foot and a history of foot
ulceration
D. Unexplained high WBC count or inflammatory markers
in a patient with a diabetic foot ulcer
E. Evidence of cortical erosion and periosteal reaction on
plain radiography
ANSWER: B
COMMENTS: See Question 44.
Ref.: See Question 44
44. Which of the following is true regarding OM in a diabetic foot?
A. A nuclear medicine-tagged WBC scan is the best way to
diagnose OM.
B. The only reported successful treatment of OM includes
resection of the infected bone.
C. A presumptive diagnosis of OM cannot be made even if
bone destruction is seen on plain film underneath an ulcer.
D. A bone biopsy is often difficult to perform and invasive
and should be avoided.
E. Selected patients may benefit from implanted antibiotics,
hyperbaric oxygen therapy, or revascularization.

A

COMMENTS: OM impairs healing of the wound and acts as a
nidus for recurrent infection. It should be suspected in any deep or
extensive ulcer, in one that overlies a bony prominence, and in an
ulcer that does not heal after 6 weeks of appropriate therapy. In
addition, concern for OM is raised in a patient with a swollen foot
and a history of foot ulceration, the presence of a “sausage toe”
(red, swollen digit), unexplained high WBC count, or inflammatory
markers. Bone destruction underneath an ulcer seen on radiographs
or probing of an ulcer down to bone is OM until proved otherwise.
MRI is the most useful available imaging modality to diagnose
OM, as well as to characterize any underlying soft tissue infection.
The “gold standard” for diagnosis of OM remains isolation of
bacteria from a bone sample with concomitant histologic findings
of inflammatory cells and osteonecrosis.
When treating a diabetic foot infection, if there are no hard signs
to indicate the presence of OM and plain radiographs do not demonstrate any evidence of bone pathology, the patient should be treated
for about 2 weeks for the soft tissue infection. If there is a persistent
concern for OM, plain films should be repeated in 2 to 4 weeks to
look for evidence of cortical erosion, periosteal reaction, or mixed
radiolucency and sclerosis. Radioisotope scans are more sensitive
than plain radiographs for diagnosis but are expensive and can be
time consuming. If findings on plain films are only consistent with
but not characteristic of OM, the clinician should consider the following: (1) additional imaging studies—MRI is preferred but nuclear
medicine scans with leukocyte or immunoglobulin techniques would
be the second choice; (2) empiric treatment for an additional 2 to 4
weeks with repeated radiographs to look for progression of bone
changes; and (3) bone biopsy (operative or percutaneous fluoroscopic or CT guidance), especially if the etiologic pathogen or susceptibilities need to be established. Some physicians would perform
biopsies for midfoot or hindfoot lesions because these are more
difficult to treat and lead to higher-level amputations.
Traditionally, resection of a bone with chronic OM was necessary for cure; however, some nonrandomized case series report
clinical success in 65%–80% of patients treated nonoperatively
with prolonged (3 to 6 months) antibiotic therapy. When treatment
of OM fails, the clinician should consider whether the original
diagnosis was correct; whether there is any remaining necrotic or
infected bone or surgical hardware that needs to be removed; and
whether the antimicrobials selected were appropriate, achieved an
effective concentration within the bone, and were used for a sufficient duration. Selected patients may benefit from implanted antibiotics, hyperbaric oxygen therapy, revascularization, long-term or
intermittent antibiotic administration, or amputation

37
Q

Which of the following regarding hospital-acquired pneumonia (HAP), VAP, and health care–associated pneumonia
(HCAP) is false?
A. They are the most common nosocomial infections.
B. They are usually caused by aerobic gram-negative bacilli.
C. They are rarely due to viral or fungal pathogens in
immunocompetent patients.CHAPTER 5 / Surgical Infection and Transmissible Diseases and Surgeons 71
D. Infection resulting from aspiration is usually due to
anaerobes.
E. Gram-positive coccal isolates are more common patients
with head trauma.
ANSWER: A
COMMENTS: See Question 46.
Ref.: See Question 46
46. Which of the following are risk factors for HAP, VAP, or
HCAP caused by multidrug-resistant pathogens?
A. Hospitalization for 5 or more days
B. Antimicrobial therapy or hospitalization in the preceding
90 days
C. Home wound care
D. Immunosuppressive disease or therapy
E. All of the above

A

ANSWER: E
COMMENTS: HAP, HCAP, and VAP are the second most common
nosocomial infections after UTI. They result in significant morbidity and mortality. They are due to a wide spectrum of bacterial
pathogens and are often polymicrobial, especially in patients with
acute respiratory distress syndrome. They are rarely due to viral or
fungal agents in immunocompetent patients. Isolation of Candida
from endotracheal aspirates of immunocompetent patients usually
represents colonization.
Common pathogens include aerobic gram-negative bacilli,
including P. aeruginosa, E. coli, K. pneumoniae, and Acinetobacter spp. There has been an emergence of pneumonia associated with gram-positive cocci (S. aureus, particularly MRSA),
and it is more commonly seen in diabetics, patients with head
trauma, and those hospitalized in the ICU. Infection with anaerobic organisms may follow aspiration in nonintubated patients but
is rare in VAP.
Early-onset HAP or VAP occurring within the first 4 days of
hospitalization carries a better prognosis than do late-onset infections
(5 days or more), which are more likely to be due to multidrugresistant bacterial pathogens and result in increased morbidity and
mortality. Additional risk factors for multidrug-resistant bacterial
pathogens such as Pseudomonas, Acinetobacter spp., MRSA, and K.
pneumoniae include antimicrobial therapy or hospitalization in the
preceding 90 days, a high frequency of antibiotic resistance in the
community or in the specific hospital unit, and immunosuppressive
disease or therapy. Risk factors for multidrug-resistant pathogens in
patients with HCAP include residence in a nursing home or longterm care facility, home infusion therapy, chronic dialysis within 30
days, home wound care, and a family member with a multidrugresistant pathogen.
P. aeruginosa is the most common gram-negative bacterial
pathogen that causes multidrug-resistant HAP/VAP, with some isolates being susceptible only to polymyxin B. Most MRSA infections are treated successfully with linezolid, although MRSA
isolates resistant to linezolid are emerging.
Early administration of a broad-spectrum antibiotic in adequate doses and deescalation of the initial antibiotic therapy based
on cultures and clinical response are essential. Failure to adequately
treat the infection because of delayed initiation of appropriate
therapy has been associated with increased mortality. Guidelines
have been established by the American Thoracic Society and the
Infectious Disease Society of America for empiric therapy in
immunocompetent adults with bacterial causes of HAP, VAP, or
HCAP; treatment should include either ceftriaxone, a fluoroquinolone, ampicillin/sulbactam, or ertapenem if there is no suspicion of
a multidrug-resistant pathogen.

38
Q
. Which of the following antimicrobial agents is considered 
safe in pregnancy?
A. Ganciclovir
B. Albendazole
C. Ketoconazole
D. Streptomycin
E. Erythromycin
A

ANSWER: E
COMMENTS: Multiple antimicrobial agents are contraindicated
in pregnancy. Of the answer choices listed above, erythromycin is
the only agent considered safe. Most penicillins and cephalosporins
are safe as well. Ganciclovir, ketoconazole, and albendazole are
teratogenic in the first trimester. Streptomycin has been shown to
cause ototoxicity in fetuses.